Akebia completes follow-on

Akebia Therapeutics Inc. (NASDAQ:AKBA), Cambridge, Mass. Business: Hematology, Cardiovascular Date completed: 2016-01-06 Type: Follow-on Raised: $65.3 million Shares: 7.3 million Price: $9 Shares afte...